Clinical Trials · NCT02084251
Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- PegBio Co., Ltd.
- Enrollment
- 70
- Start date
- Feb 2014
- Locations
- 1 site, China
- Primary endpoint
- Safety/Adverse Event Outcome Measure